Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|May 24, 2025
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trialInger Jorid Berg, Eirik K Kristianslund, Anne Therese Tveter, et al.
Rheumatology (Oxford, England)|December 28, 2020
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Arthritis Care & Research|November 30, 2020
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment CoursesBente Glintborg, Ulf Lindström, Daniela Di Giuseppe, et al.
BMC Medicine|October 5, 2022
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyIngrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open|February 20, 2025
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritisStylianos Georgiadis, Marion Pons, Simon Rasmussen, et al.
Seminars in Arthritis and Rheumatism|February 1, 2024
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practiceSara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, et al.
Annals of the Rheumatic Diseases|July 13, 2026
Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countriesBrigitte Michelsen, Christos Polysopoulos, Michael J Nissen, et al.
RMD Open|May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritisZohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
RMD Open|July 25, 2024
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational studySara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, et al.
Pageof 5